Fn14 Controls the SIRT2‐Mediated Deacetylation of Slug to Inhibit the Metastasis of Epithelial Ovarian Cancer
Advanced Science · 2025
DOI: 10.1002/advs.202501552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Anyue Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, 200127, China. Hauptthemen laut MEDLINE: Snail Family Transcription Factors, Carcinoma, Ovarian Epithelial, Sirtuin 2, Ovarian Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Innovation And Cultivation Fund of Renji Hospital, Shanghai Jiao Tong University School of Medicine, Star Program of Shanghai Jiao Tong University of Medical Engineering Fund.
Abstract (Originalsprache)
Metastatic spread of cancer is the leading cause of death in patients with epithelial ovarian cancer (EOC), and elucidation of the molecular mechanisms underlying this process is a major focus of cancer research. Fibroblast growth factor‐inducible 14 (Fn14) has been shown to regulate wound repair, inflammation, angiogenesis, and chemoresistance, but its functional role in metastasis in EOC is still unknown. Here it is reported that Fn14 is identified as a cancer metastasis suppressor that inhibits the migratory and invasive potential of EOC cells by down‐regulating epithelial‐mesenchymal transition (EMT). Mechanistically, it is identified that Fn14 promotes acetylation‐dependent protein degradation of Slug, a key transcriptional factor associated with EMT. The deacetylase Sirtuin 2 (SIRT2) has been reported to be involved in the deacetylation of Slug protein to stabilize it and then prevent its degradation in the nucleus. The results showed that Fn14 alters the subcellular localization of (SIRT2) by interacting with SIRT2, leading to reduced SIRT2 shuttling into the nucleus and subsequently promoting the acetylated degradation of Slug. Collectively, the work has demonstrated for the first time that Fn14 inhibits EOC metastasis by regulating SIRT2‐mediated Slug deacetylation, providing a new perspective and method for the development of future novel therapeutic strategies for the treatment of EOC metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, 200127, China.
- Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, 200127, China.
- Department of Histoembryology, Genetics and Developmental Biology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Key Laboratory of Reproductive Medicine, Shanghai Jiao T…
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Förderung
- National Natural Science Foundation of China
- Innovation And Cultivation Fund of Renji Hospital, Shanghai Jiao Tong University School of Medicine
- Star Program of Shanghai Jiao Tong University of Medical Engineering Fund
Zitieren
APA
Wu, A., Li, S., Feng, C., He, R., Wu, R., Hu, Z., Huang, J., Wang, W., Huang, L., & Qiu, L. (2025). Fn14 Controls the SIRT2‐Mediated Deacetylation of Slug to Inhibit the Metastasis of Epithelial Ovarian Cancer. Advanced Science. https://doi.org/10.1002/advs.202501552
Vancouver
Wu A, Li S, Feng C, He R, Wu R, Hu Z, et al. Fn14 Controls the SIRT2‐Mediated Deacetylation of Slug to Inhibit the Metastasis of Epithelial Ovarian Cancer. Advanced Science. 2025. doi:10.1002/advs.202501552
BibTeX
@article{Wu2025,
author = {Wu, Anyue and Li, Shengze and Feng, Chunyang and He, Ruiju and Wu, Ruolan and Hu, Zhijun and Huang, Jinhua and Wang, Wenjing and Huang, Lei and Qiu, Lihua},
title = {Fn14 Controls the SIRT2‐Mediated Deacetylation of Slug to Inhibit the Metastasis of Epithelial Ovarian Cancer},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202501552}
}
EUVIMED